Clinical Trial Update: Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated driving performance effects of Amphetamine Extended Release Tablets in adults with ADHD; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Amphetamine Extended Release Tablets

Snippet

Sponsor: Tris Pharma, Inc. | Conditions: ADHD | Phase 2 | Status: COMPLETED